Natural regulatory T cells in infectious disease

Nature Immunology

Volumn 6, Issue 4, 2005, Pages 353-360

  Belkaid, Yasmine ^a,c   Rouse, Barry T ^b  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR;

ANTIGEN SPECIFICITY; CELL FUNCTION; IMMUNE RESPONSE; INFECTION; MICROORGANISM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; TISSUE INJURY; ANIMAL; BACTERIAL INFECTION; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; MICROBIOLOGY; MOUSE; PARASITOLOGY; PROTOZOAL INFECTION; VIROLOGY; VIRUS INFECTION;

ANIMALS; ANTIGENS, CD4; BACTERIAL INFECTIONS; HUMANS; IMMUNOTHERAPY; MICE; PROTOZOAN INFECTIONS; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES; VIRUS DISEASES;

EID: 16844369607     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1181     Document Type: Review

References (81)

1. Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M. & Toda, M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1164 (1995).
2. Bluestone, J.A. & Abbas, A.K. Natural versus adaptive regulatory T cells. Nat. Rev. Immunol. 3, 253-257 (2003).
3. + immunoregulatory T cells: central players in the arena of peripheral tolerance. Semin. Immunol. 16, 81-88 (2004).
4. Mills, K.H. & McGuirk, P. Antigen-specific regulatory T cells-their induction and role in infection. Semin. Immunol. 16, 107-117 (2004).
5. + Tregs: limiting collateral damage. J. Clin. Invest. 114, 1372-1378 (2004).
6. Fontenot, J.D. & Rudensky, A. A well adapted regulatory contrivance: regulatory T cell development and the Forkhead family transcription factor Foxp3. Nat. Immunol. 6, 331-337 (2005).
7. Powrie, F., Read, S., Mottet, C., Uhlig, H. & Maloy, K. Control of immune pathology by regulatory T cells. Novartis Found. Symp. 252, 92-8 (2003).
8. + T regulatory cells suppress Helicobacter hepaticus-induced colitis. J. Exp. Med. 196, 505-515 (2002).
9. R cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197, 111-119 (2003).
10. R cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 197, 111-119 (2003).
11. + regulatory T cells is associated with a loss of regulation leading to increased pathology in Helicobacter pylori-infected mice. Clin. Exp. Immunol. 132, 393-400 (2003).
12. high regulatory T cells suppress memory T-cell responses to H. pylori in infected individuals. Infect. Immun. 71, 1755-1762 (2003).
13. Hori, S., Carvalho, T.L. & Demengeot, J. CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur. J. Immunol. 32, 1282-1291 (2002).
14. Montagnoli, C. et al. B7/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J. Immunol. 169, 6298-6308 (2002).
15. Sacks, D. & Noben-Trauth, N. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2, 845-858 (2002).
16. + T cells. J. Immunol. 169, 3232-3241 (2002).
17. + regulatory T cells suppress differentiation and functions of Th1 and Th2 cells, Leishmania major infection, and colitis in mice. J. Immunol. 170, 394-399 (2003).
18. + regulatory T cells cure murine colitis: the role of IL-10, TGF-β, and CTLA4. J. Immunol. 171, 5012-5017 (2003).
19. + cells contribute to Th2 polarization during helminth infection by suppressing Th1 response development. J. Immunol. 173, 1224-1231 (2004).
20. Hesse, M. et al. The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J. Immunol. 172, 3157-3166 (2004).
21. + regulatory T lymphocytes in hepatitis C virus infection. Hepatology 40, 1062-1071 (2004).
22. + regulatory T cells control the severity of viral immunoinflammatory lesions. J. Immunol. 172, 4123-4132 (2004).
23. + regulatory T cells control Leishmania major persistence and immunity. Nature 420, 502-507 (2002).
24. Belkaid, Y. et al. A natural model of Leishmania major infection reveals a prolonged 'silent' phase of parasite amplification in the skin before the onset of lesion formation and immunity. J. Immunol. 165, 969-977 (2000).
25. Good, M.F., Xu, H., Wykes, M. & Engwerda, C.R. Development and regulation of cell-mediated immune responses to the blood stages of malaria: implications for vaccine research. Annu. Rev. Immunol. (in the press).
26. + regulatory T cells. Nat. Med. 10, 29-30 (2004).
27. + T cells on Plasmodium berghei NK65 infection in BALB/c mice. Int. J. Parasitol. 33, 175-183 (2003).
28. + T cell responses. J. Exp. Med. 198, 889-901 (2003).
29. + regulatory T cells induced by chronic retroviral infection. Proc. Natl. Acad. Sci. USA 98, 9226-9230 (2001).
30. + T cells by regulatory T cells during persistent retroviral infection. Immunity 20, 293-303 (2004).
31. Beilharz, M.W. et al. Timed ablation of regulatory CD4+ T cells can prevent murine AIDS progression. J. Immunol. 172, 4917-4925 (2004).
32. + regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J. Virol. 78, 2454-2459 (2004).
33. + HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J. Exp. Med. 200, 331-343 (2004).
34. + regulatory T cells which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood 104, 3249-3256 (2004).
35. Sugimoto, K. et al. Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology 38, 1437-1448 (2003).
36. + regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis. Blood 103, 3428-3430 (2004).
37. + regulatory T cells in reactivation of persistent leishmaniasis and control of concomitant immunity. J. Exp. Med. 200, 201-210 (2004).
38. + T cell responses. J. Exp. Med. 196, 1585-1592 (2002).
39. + T cell responses against herpes simplex virus. J. Virol. 78, 13082-13089 (2004).
40. Rajagopalan, S. Tuberculosis and aging: a global health problem. Clin. Infect. Dis. 33, 1034-1039 (2001).
41. Gane, E. & Pilmore, H. Management of chronic viral hepatitis before and after renal transplantation. Transplantation 74, 427-437 (2002).
42. + regulatory T cells in vivo. J. Exp. Med. 198, 249-258 (2003).
43. Klein, L., Khazaie, K. & von Boehmer, H. In vivo dynamics of antigen-specific regulatory T cells not predicted from behavior in vitro. Proc. Natl. Acad. Sci. USA 100, 8886-8891 (2003).
44. Hori, S., Haury, M., Lafaille, J.J., Demengeot, J. & Coutinho, A. Peripheral expansion of thymus-derived regulatory cells in anti-myelin basic protein T cell receptor transgenic mice. Eur. J. Immunol. 32, 3729-3735 (2002).
45. Mellor, A.L. & Munn, D.H. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat. Rev. Immunol. 4, 762-774 (2004).
46. Pawelec, G. et al. Is human immunosenescence clinically relevant? Looking for 'immunological risk phenotypes'. Trends Immunol. 23, 330-332 (2002).
47. + T cells in mice. Eur. J. Immunol. 33, 2449-2458 (2003).
48. +CD25- T cells in aged mice are hyporesponsive and exhibit suppressive activity. J. Immunol. 170, 1675-1682 (2003).
49. Raghavan, S., Suri-Payer, E. & Holmgren, J. Antigen-specific in vitro suppression of murine Helicobacter pylori-reactive immunopathological T cells by CD4CD25 regulatory T cells. Scand. J. Immunol. 60, 82-88 (2004).
50. MacDonald, A.J. et al. CD4 T helper type 1 and regulatory T cells induced against the same epitopes on the core protein in hepatitis C virus-infected persons. J. Infect. Dis. 185, 720-727 (2002).
51. Wucherpfennig, K.W. & Strominger, J.L. Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein. Cell 80, 695-705 (1995).
52. von Herrath, M.G., Evans, C.F., Horwitz, M.S. & Oldstone, M.B. Using transgenic mouse models to dissect the pathogenesis of virus-induced autoimmune disorders of the islets of Langerhans and the central nervous system. Immunol. Rev. 152, 111-143 (1996).
53. Rouse, B.T. & Deshpande, S. Viruses and autoimmunity: an affair but not a marriage contract. Rev. Med. Virol. 12, 107-113 (2002).
54. de Oliveira, M.R. et al. Influence of microbiota in experimental cutaneous leishmaniasis in Swiss mice. Rev. Inst. Med. Trop. Sao Paulo 41, 87-94 (1999).
55. Singer, S.M. & Nash, T.E. The role of normal flora in Giardia lamblia infections in mice. J. Infect. Dis. 181, 1510-1512 (2000).
56. + T cells independent of cellular proliferation. Virology 321, 307-322 (2004).
57. Caramalho, I. et al. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 197, 403-411 (2003).
58. + regulatory T cells by antigen-processing dendritic cells. J. Exp. Med. 198, 235-247 (2003).
59. Oswald-Richter, K. et al. HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol. 7, 955-966 (2004).
60. Andersson, J. et al. Cutting edge: the prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J. Immunol. 174, 3143-3147 (2005).
61. + T cells through TGF-β-TGF-β receptor interactions in type 1 diabetes. Proc. Natl. Acad. Sci. USA 100, 10878-10883 (2003).
62. + regulatory T cells by TGF-B induction of transcription factor Foxp3. J. Exp. Med. 198, 1875-1886 (2003).
63. - cells to develop suppressive activity: the role of IL-2, TGF-γ, and IL-10. J. Immunol. 172, 5213-5221 (2004).
64. Bystry, R.S., Aluvihare, V., Welch, K.A., Kallikourdis, M. & Setz, A.G. B cells and professional APCs recruit regulatory T cells via CCL4. Nat. Immunol. 2, 1126-1132 (2001).
65. + regulatory T cells. J. Exp. Med. 194, 847-853 (2001).
66. + splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7. J. Immunol. 169, 2461-2465 (2002).
67. + T cell-mediated suppression by dendritic cells. Science [comment] 299, 1033-1036 (2003).
68. + T cells. J. Leukoc. Biol. 75, 785-791 (2004).
69. + T cells. Immunity 19, 877-889 (2003).
70. Gangappa, S., Manickan, E. & Rouse, B.T. Control of herpetic stromal keratitis using CTLA4Ig fusion protein. Clin. Immunol. Immunopathol. 86, 88-94 (1998).
71. Belkaid, Y. et al. The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure. J. Exp. Med. 194, 1497-1506 (2001).
72. Murphy, M.L., Cotterell, S.E., Gorak, P.M., Engwerda, C.R. & Kaye, P.M. Blockade of CTLA-4 enhances host resistance to the intracellular pathogen, Leishmania donovani. J. Immunol. 161, 4153-4160 (1998).
73. + immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 16, 311-323 (2002).
74. + T cells. J. Immunol. 173, 5008-5020 (2004).
75. He, H. et al. Reduction of retrovirus-induced immunosuppression by in vivo modulation of T cells during acute infection. J. Virol. 78, 11641-11647 (2004).
76. + regulatory T cells. J. Immunol. 170, 3939-3943 (2003).
77. Belghith, M. et al. TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat. Med. 9, 1202-1208 (2003).
78. + immune regulatory cells inhibits graft-versus-host disease lethality. Blood 99, 3493-3499 (2002).
79. Hori, S., Nomura, T. & Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061 (2003).
80. Netea, M.G. et al. Toll-like receptor 2 suppresses immunity against Candida albicans through induction of IL-10 and regulatory T cells. J. Immunol. 172, 3712-3718 (2004).
81. + T regulatory cells. J. Immunol. 172, 4752-4761 (2004).